Celldex Therapeutics Inc (CLDX)
Operating Cash Flow Growth
-30.46%
Quarterly · Period ending:
CLDX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-30.46%period ending
Latest reported-30.46%period ending
CLDX Quarterly Cash from Operations YoY % (-105.56% → -30.46%)
Year-over-year change
High-resolution chart · PNG
CLDX operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -53.4796% | |
| -540.2623% | |
| 76.8219% | |
| -4.7958% | |
| -13.06% | |
| 149.8708% | |
| -12.6455% | |
| 36.8421% | |
| -19.0476% | |
| -26.3158% | |
| 47.619% | |
| -90% | |
| -40% | |
| 9.5238% | |
| -10.5263% | |
| 20% | |
| 42.3077% | |
| 22.2222% | |
| -311.1111% | |
| 24.2424% | |
| -8.3333% | |
| 12.9032% | |
| 133.3333% | |
| -65% | |
| 0% | |
| -55% | |
| -170% | |
| -66.6667% | |
| -41.1765% | |
| -25% | |
| 20% | |
| -54.5455% | |
| -23.0769% | |
| 0% | |
| -37.5% | |
| -1,200% | |
| 50% | |
| 6.25% | |
| -166.6667% | |
| -105.5556% |